Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 85: 1070-1078, 1998;
8750-7587/98 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, D. U.
Right arrow Articles by Rich, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, D. U.
Right arrow Articles by Rich, G. F.
Vol. 85, Issue 3, 1070-1078, September 1998

Regulation of the endogenous NO pathway by prolonged inhaled NO in rats

Deborah U. Frank1, Damian J. Horstman1, Geoffrey N. Morris2, Roger A. Johns2, and George F. Rich2

Departments of 1 Biomedical Engineering and 2 Anesthesiology, University of Virginia Health System, Charlottesville, Virginia 22906-0010

Nitric oxide (NO) modulates the endogenous NO-cGMP pathway. We determined whether prolonged inhaled NO downregulates the NO-cGMP pathway, which may explain clinically observed rebound pulmonary hypertension. Rats were placed in a normoxic (N; 21% O2) or hypoxic (H; 10% O2) environment with and without inhaled NO (20 parts/million) for 1 or 3 wk. Subsequently, nitric oxide synthase (NOS) and soluble guanylate cyclase (GC) activity and endothelial NOS (eNOS) protein levels were measured. Perfusate cGMP levels and endothelium-dependent and -independent vasodilation were determined in isolated lungs. eNOS protein levels and NOS activity were not altered by inhaled NO in N or H rats. GC activity was decreased by 60 ± 10 and 55 ± 11% in N and H rats, respectively, after 1 wk of inhaled NO but was not affected after 3 wk. Inhaled NO had no effect on perfusate cGMP in N lungs. Inhaled NO attenuated the increase in cGMP levels caused by 3 wk of H by 57 ± 11%, but there was no rebound in cGMP after 24 h of recovery. Endothelium-dependent vasodilation was not altered, and endothelium-independent vasodilation was not altered (N) or slightly increased (H, 10 ± 3%) by prolonged inhaled NO. In conclusion, inhaled NO did not alter the endogenous NO-cGMP pathway as determined by eNOS protein levels, NOS activity, or endothelium-dependent vasodilation under N and H conditions. GC activity was decreased after 1 wk; however, GC activity was not altered by 3 wk of inhaled NO and endothelium-independent vasodilation was not decreased.

nitric oxide; pulmonary hypertension; chronic hypoxia; nitric oxide synthase; guanylate cyclase; cyclic 3',5'-guanosine monophosphate; pulmonary vasodilation


This article has been cited by other articles:


Home page
 FASEB J.Home page
M. Kirsch, B. Kemp-Harper, N. Weissmann, F. Grimminger, and H. H. H. W. Schmidt
Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling
FASEB J, January 1, 2008; 22(1): 30 - 40.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. M. Williams, C. R. White, M. M. Chang, E. R. Injeti, L. Zhang, and W. J. Pearce
Chronic hypoxic decreases in soluble guanylate cyclase protein and enzyme activity are age dependent in fetal and adult ovine carotid arteries
J Appl Physiol, June 1, 2006; 100(6): 1857 - 1866.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. H. Han, E. Qamirani, A. G. Nelson, D. R. Hyduke, G. Chaudhuri, L. Kuo, and J. C. Liao
Regulation of nitric oxide consumption by hypoxic red blood cells
PNAS, October 14, 2003; 100(21): 12504 - 12509.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
V. Hampl and J. Herget
Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension
Physiol Rev, October 1, 2000; 80(4): 1337 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Black, R. S. Heidersbach, D. M. McMullan, J. M. Bekker, M. J. Johengen, and J. R. Fineman
Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1849 - H1856.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. J. Horstman, D. A. McCall, D. U. Frank, and G. F. Rich
Inhaled Nitric Oxide and Nifedipine Have Similar Effects on Lung cGMP Levels in Rats
Anesth. Analg., October 1, 1999; 89(4): 932 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. S Hayward, R. P Kelly, and P. S Macdonald
Inhaled nitric oxide in cardiology practice
Cardiovasc Res, August 15, 1999; 43(3): 628 - 638.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. J. Horstman, L. G. Fischer, P. C. Kouretas, R. L. Hannan, and G. F. Rich
Role of nitric oxide in heparin-induced attenuation of hypoxic pulmonary vascular remodeling
J Appl Physiol, May 1, 2002; 92(5): 2012 - 2018.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online